CO2024001716A2 - Derivados de piridina sustituida como inhibidores de sarm1 - Google Patents
Derivados de piridina sustituida como inhibidores de sarm1Info
- Publication number
- CO2024001716A2 CO2024001716A2 CONC2024/0001716A CO2024001716A CO2024001716A2 CO 2024001716 A2 CO2024001716 A2 CO 2024001716A2 CO 2024001716 A CO2024001716 A CO 2024001716A CO 2024001716 A2 CO2024001716 A2 CO 2024001716A2
- Authority
- CO
- Colombia
- Prior art keywords
- pyridine derivatives
- substituted pyridine
- sarm1 inhibitors
- sarm1
- inhibitors
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 101000685982 Homo sapiens NAD(+) hydrolase SARM1 Proteins 0.000 abstract 1
- 102100023356 NAD(+) hydrolase SARM1 Human genes 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Esta divulgación se refiere a los derivados de la piridina, las composiciones de los mismos, y métodos asociados, útiles para la inhibición de la actividad de SARM1 y/o para el tratamiento o prevención de trastornos neurológicos.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163226557P | 2021-07-28 | 2021-07-28 | |
| US202263305103P | 2022-01-31 | 2022-01-31 | |
| US202263368034P | 2022-07-08 | 2022-07-08 | |
| PCT/US2022/038577 WO2023009663A1 (en) | 2021-07-28 | 2022-07-27 | Substituted pyridine derivatives as sarm1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024001716A2 true CO2024001716A2 (es) | 2024-03-07 |
Family
ID=85087993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0001716A CO2024001716A2 (es) | 2021-07-28 | 2024-02-19 | Derivados de piridina sustituida como inhibidores de sarm1 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11629136B1 (es) |
| EP (1) | EP4376840A1 (es) |
| KR (1) | KR20240041987A (es) |
| AU (1) | AU2022320699A1 (es) |
| CA (1) | CA3226869A1 (es) |
| CO (1) | CO2024001716A2 (es) |
| IL (1) | IL310403A (es) |
| TW (1) | TW202313009A (es) |
| WO (1) | WO2023009663A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022031736A1 (en) | 2020-08-04 | 2022-02-10 | Nura Bio, Inc. | Substituted pyridine derivatives as sarm1 inhibitors |
| CN116438171A (zh) | 2020-09-16 | 2023-07-14 | 努拉生物公司 | 作为sarm1抑制剂的取代的吡啶衍生物 |
| IL310403A (en) * | 2021-07-28 | 2024-03-01 | Nura Bio Inc | Converted pyridine derivatives as SARM1 inhibitors |
| CN113655155A (zh) * | 2021-07-28 | 2021-11-16 | 任贤金 | 一种测定sph3127有关物质的方法 |
| WO2024026368A1 (en) * | 2022-07-27 | 2024-02-01 | Nura Bio, Inc. | Substituted pyridine derivatives as sarm1 inhibitors |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1019391A1 (en) | 1997-10-02 | 2000-07-19 | Merck & Co. Inc. | Inhibitors of prenyl-protein transferase |
| JP2005504789A (ja) | 2001-09-13 | 2005-02-17 | シンタ ファーマスーティカルズ コーポレイション | 癌治療のための２−アロイルイミダゾール化合物 |
| DE102004009933A1 (de) | 2004-02-26 | 2005-09-15 | Merck Patent Gmbh | Verwendung von Thiadiazolharnstoffderivaten |
| ATE464303T1 (de) | 2004-04-28 | 2010-04-15 | Vertex Pharma | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen |
| PE20060426A1 (es) | 2004-06-02 | 2006-06-28 | Schering Corp | DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa |
| DK2197849T3 (da) | 2007-10-09 | 2013-03-25 | Merck Patent Gmbh | N-(pyrazol-3-yl)-benzamidderivater som glucosinaseaktivatorer |
| WO2009114552A1 (en) * | 2008-03-10 | 2009-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| US8785468B2 (en) | 2009-02-13 | 2014-07-22 | Amgen Inc. | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions |
| EP2627653B1 (en) | 2010-10-13 | 2014-12-24 | Glaxo Group Limited | 3-amino-pyrazole derivatives useful against tuberculosis |
| WO2012050141A1 (ja) | 2010-10-14 | 2012-04-19 | 住友化学株式会社 | ヘテロ芳香環化合物およびその有害生物防除用途 |
| AR096393A1 (es) | 2013-05-23 | 2015-12-30 | Bayer Cropscience Ag | Compuestos heterocíclicos pesticidas |
| WO2015175704A1 (en) | 2014-05-14 | 2015-11-19 | The Regents Of The University Of California | Inhibitors of bacterial dna gyrase with efficacy against gram-negative bacteria |
| CA2955872A1 (en) | 2014-07-24 | 2016-01-28 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| EP3297437A4 (en) | 2015-05-18 | 2019-02-27 | Translational Drug Development Llc | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KINASES |
| US20170355708A1 (en) | 2016-06-09 | 2017-12-14 | Cadent Therapeutics, Inc. | Potassium channel modulators |
| CA3082254A1 (en) | 2016-11-21 | 2018-05-24 | Translational Drug Development, Llc | Heterocyclic compounds as kinase inhibitors |
| MA52812A (fr) | 2018-06-07 | 2021-04-14 | Disarm Therapeutics Inc | Inhibiteurs de sarm1 |
| BR112021017049A2 (pt) | 2019-02-28 | 2022-02-08 | Kezar Life Sciences | Derivados de tiazol como inibidores de secreção de proteínas |
| EP3980011A4 (en) | 2019-06-06 | 2023-01-18 | Disarm Therapeutics, Inc. | MRSA1 INHIBITORS |
| WO2020252229A2 (en) | 2019-06-14 | 2020-12-17 | Disarm Therapeutics, Inc. | Inhibitors of sarm1 |
| MX2022008395A (es) | 2020-01-07 | 2022-09-26 | Disarm Therapeutics Inc | Inhibidores de sarm1. |
| WO2022031736A1 (en) | 2020-08-04 | 2022-02-10 | Nura Bio, Inc. | Substituted pyridine derivatives as sarm1 inhibitors |
| TWI786777B (zh) | 2020-08-24 | 2022-12-11 | 美商達薩瑪治療公司 | Sarm1之抑制劑 |
| CN116438171A (zh) | 2020-09-16 | 2023-07-14 | 努拉生物公司 | 作为sarm1抑制剂的取代的吡啶衍生物 |
| IL310403A (en) * | 2021-07-28 | 2024-03-01 | Nura Bio Inc | Converted pyridine derivatives as SARM1 inhibitors |
-
2022
- 2022-07-27 IL IL310403A patent/IL310403A/en unknown
- 2022-07-27 US US17/875,301 patent/US11629136B1/en active Active
- 2022-07-27 TW TW111128145A patent/TW202313009A/zh unknown
- 2022-07-27 WO PCT/US2022/038577 patent/WO2023009663A1/en active Application Filing
- 2022-07-27 EP EP22850281.1A patent/EP4376840A1/en active Pending
- 2022-07-27 AU AU2022320699A patent/AU2022320699A1/en active Pending
- 2022-07-27 CA CA3226869A patent/CA3226869A1/en active Pending
- 2022-07-27 KR KR1020247006685A patent/KR20240041987A/ko unknown
-
2023
- 2023-03-03 US US18/178,325 patent/US20230286941A1/en active Pending
-
2024
- 2024-02-19 CO CONC2024/0001716A patent/CO2024001716A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4376840A1 (en) | 2024-06-05 |
| US20230105696A1 (en) | 2023-04-06 |
| KR20240041987A (ko) | 2024-04-01 |
| WO2023009663A1 (en) | 2023-02-02 |
| AU2022320699A1 (en) | 2024-02-29 |
| US11629136B1 (en) | 2023-04-18 |
| TW202313009A (zh) | 2023-04-01 |
| CA3226869A1 (en) | 2023-02-02 |
| US20230286941A1 (en) | 2023-09-14 |
| IL310403A (en) | 2024-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2024001716A2 (es) | Derivados de piridina sustituida como inhibidores de sarm1 | |
| CL2020001576A1 (es) | Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5. | |
| ECSP22087539A (es) | Inhibidores de kras tricíclicos fusionados | |
| CO2019014455A2 (es) | Amidas heterocíclicas de 5 miembros y bicíclicas como inhibidores de rock | |
| CL2020002146A1 (es) | Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer. | |
| CO2018008173A2 (es) | Salicilamidas de espiroheptanos y compuestos relacionados como inhibidores de cinasa rho (rock) | |
| DOP2021000234A (es) | Pirroles triciclicos condensados como moduladores de alfa-1 antitripsina | |
| BR112021021754A2 (pt) | Cicloalquilas substituídas como moduladoras da via de estresse integrada | |
| MX2020007265A (es) | Derivados de rapamicina. | |
| PH12021550187A1 (en) | Pyrrolopyrimidine itk inhibitors | |
| CO2021008018A2 (es) | Composiciones y métodos para modular la actividad de deshidrogenasas de cadena corta | |
| NI201700029A (es) | Compuestos y composiciones como inhibidores de quinasa raf. | |
| CL2023000371A1 (es) | Composiciones y métodos para inhibir la expresión de plp1. | |
| CO2021001219A2 (es) | Benzimidazoles sustituidos como inhibidores de pad4 | |
| ECSP20061378A (es) | COMPUESTOS DIÓLICOS DE AMINOPIRAZINA COMO INHIBIDORES DE PI3K-gamma | |
| CO2017000011A2 (es) | Derivados de quinolizinona como inhibidores de pi3k | |
| CL2019003107A1 (es) | Compuestos heterocíclicos bicíclicos sustituidos utilizados como inhibidores de nadph oxidasa. | |
| CL2023002223A1 (es) | Inhibidores de cdk2 y métodos de uso de los mismos | |
| CO6630193A2 (es) | Inhibidores de la actividad de la proteína tirosina quinasa seleccionada | |
| CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
| CL2022001887A1 (es) | Pirazolo-pirimidinas sustituidas y usos de las mismas | |
| ECSP21010874A (es) | Piridopirimidinas como inhibidores del receptor de histamina h4 | |
| BR112022018929A2 (pt) | Inibidores da ciclofilina e seus usos | |
| BR112022010943A2 (pt) | Análogos de nucleosídeos substituídos como inibidores de prmt5 | |
| DOP2020000088A (es) | Derivados de piridinona y su uso como inhibidores selectivos de alk2. |